Fundsmith Investment Services Ltd. Johnson & Johnson Transaction History

Fundsmith Investment Services Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $1.51 Million - $1.65 Million	10,381 Added 12.78%	91,630 $14.4 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $124,444 - $139,409	799 Added 0.99%	81,249 $12.7 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $376,614 - $405,308	2,440 Added 3.13%	80,450 $13.3 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $193,041 - $230,372	1,278 Added 1.67%	78,010 $12.1 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $3.93 Million - $4.41 Million	24,519 Added 46.96%	76,732 $13.6 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $883,604 - $983,231	-5,477 Reduced 9.49%	52,213 $8.53 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $9.12 Million - $10.4 Million	57,690 New	57,690 $10.2 Million

4,227

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Fundsmith Investment Services Ltd., based on Form 13F filings with the SEC.

Stay updated on Fundsmith Investment Services Ltd. with notifications on news.